Chirine Rafia

A dramatic impairment of the antitumor activity of human Vγ9Vδ2 T cells is induced by TGF-β through significant phenotype, transcriptomic and metabolic changes

C. Pecqueur, C. Harly, E. Scotet, 2022, bioRxiv.

Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors

C. Harly, E. Scotet, Chirine Rafia, 2020, Immunological reviews.

The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes

C. Pecqueur, C. Harly, E. Scotet, 2023, Frontiers in Immunology.

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.

D. Olive, R. Hoet, C. Cano, 2021, Cell reports.